NVS Stock Ownership Activity

NOVARTIS AG-SPONSORED ADR 13F holders

4 value investing gurus have made changes to the NOVARTIS AG-SPONSORED ADR (NVS) position according to the gurus' latest SEC quarterly report(s). The number of NVS shares has been increased by 1, decreased by 3 super investor(s).

Which gurus or hedge funds are buying NVS now?

According to the latest SEC filing(s) NOVARTIS AG-SPONSORED ADR (NVS) has been bought by Thomas Graham, Alan, Irving Kahns - Kahn Brothers Group (added shares +3.44%).

To see more about who is investing in NOVARTIS AG-SPONSORED ADR (NVS), please go to the NVS ownership page.

2021 Q4 (1 result)
Parnassus Investments
buy
+1,242,128
+2.01%
2.01%
Current price: $117.79 34.66% Reported price*: $87.47
2019 Q3 (2 results)
V. D. Dodge, E. M. Cox
buy
+9,725,128
+2.23%
1.25%
Jim Cullen
buy
+9,600
+2.14%
2.14%
Current price: $117.79 35.55% AVG reported price*: $86.90
2017 Q4 (1 result)
Thomas Russo
buy
+120
+0.00%
0.00%
Current price: $117.79 46.47% Reported price*: $80.42
2014 Q2 (1 result)
C.T. Fitzpatrick
buy
+446
+0.00%
0.00%
Current price: $117.79 28.73% Reported price*: $91.50
2013 Q2 (4 results)
B. Tweedy, Ch. Browne
buy
+296,095
+0.52%
0.52%
Harry Burn
buy
+1,712,768
+2.36%
2.36%
Thomas Graham, Alan, Irving Kahns
buy
+30,368
+0.33%
0.33%
Sarah Ketterer
buy
+50,367
+0.44%
0.38%
Current price: $117.79 66.59% AVG reported price*: $70.71
9 of 9

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.